Skip to main content
OpenTrials
Completed

NCT Number: NCT04243538

Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms in Home Hospice

With the growth of hospice, older adults have the opportunity to receive home-based care aimed at reducing suffering and focusing on quality of life at the end of life. While use of technology and educational videos has yet to be fully developed, structured, and evaluated in home hospice care, it has shown promise to improve care in other settings. Therefore, this study aims to develop and evaluate a multi-component technology-based care intervention, i.e., Improving Home hospice Management of End of life issues through technology (I-HoME).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hospice

Age range

18 year–110 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Visiting Nurse Service of New York

New York, 10017, United States

About this study

The study intervention focuses on assessing and addressing patient symptoms in the home hospice setting through weekly telehealth visits (for up to 6 weeks) and educational videos that are geared for the patient's informal caregiver. The aim of this phase of the project is two fold. One is that the study team will conduct a single armed (N=6 dyads) pilot study with a focus on optimizing data collection protocols and the intervention. After this step, a randomized pilot study evaluating the feasibility and potential efficacy of I-HoME (N=50 dyads) compared to usual care (N=50 dyads) will be conducted.

Phase I of the study to assess feasibility of the intervention was registered on ClinicalTrials.gov as NCT04074304.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Home hospice caregivers must be:

  • English speaking
  • 18 years of age or older
  • not blind
  • having a family member receiving home hospice care

Home hospice patients must be:

  • English speaking
  • 65 years of age or older
  • not blind
  • enrolled in home hospice care.

Exclusion criteria

  • Patients with a terminal diagnosis of dementia or patients who have cognitive impairment and unable to sign a written informed consent will be excluded.

Treatment and study plan

I-HoME

Behavioral

I-HoME will consist of two components: (1) synchronous live video interactions between patients/CGs and a hospice nurse; and (2) educational videos.

Primary outcomes

  1. Participant Recruitment Rate

    Time frame: During recruitment (22 months)

    Recruitment rate was measured by the number of participants consented divided by the number of eligible participants.

  2. Participant Attrition From Enrollment to End of Study

    Time frame: At the end of the intervention or at 6 weeks, which ever is earlier.

    This measure is the total number of participants who withdrew consent or were unreachable for study activities after consent.

  3. Average Length of I-HoME Tele-visit

    Time frame: At the end of the intervention or at 6 weeks, which ever is earlier.

    This measure was collected by calculating the average duration (in minutes) of each tele-visit between the participant in I-HoME intervention arm and the interventionalist.

  4. Total Number of Educational Videos Watched by I-HoME Intervention Arm Participants

    Time frame: At the end of the intervention or at 6 weeks, which ever is earlier.

    This measure is the total number of videos watched by the I-HoME intervention arm participants who received at least one tele-visit. Intervention arm participants self-reported whether they watched the educational videos recommended to them by the interventionist.

  5. Number of I-HoME Intervention Caregivers Who Experienced Technical Issues During the Tele-visits.

    Time frame: At the end of the intervention or at 6 weeks, which ever is earlier.

    The number of I-HoME intervention caregivers who reported at least one technical issues with the tele-visit. Participants in the intervention arm answered questions about whether they experienced technical issues.

  6. Percentage of Tele-visits With Hardware Issues Out of the Total Number of Tele-visit Intervention Visits

    Time frame: At the end of the intervention or at 6 weeks, which ever is earlier.

    After each intervention visit, participants answered questions about whether they experienced technical issues. This measure was calculated by dividing the number of I-HoME tele-visits during which the participant and/or the interventionist experienced hardware issues by the total number of I-HoME tele-visits administered during the entire study period.

  7. Percentage of Tele-visits Conducted Out of the Total Possible Tele-visits.

    Time frame: At the end of the intervention or at 6 weeks, which ever is earlier.

    This measure is calculated by dividing the tele-visits conducted out of the total possible tele-visits. This measure shows the adherence of the I-HoME intervention arm to the tele-visits.

Secondary outcomes

  1. Patients' Symptom Burden Score as Rated by the Caregiver, Measured at Baseline and Weekly for 6 Weeks.

    Time frame: At baseline and weekly for 6 weeks.

    Symptom burden score as measured by the Edmonton Symptom Assessment Scale (ESAS). Scale is from a 0 to 90, with higher scores indicating higher symptom burden.

  2. Number of Patient Hospitalizations From Enrollment to End of Intervention

    Time frame: From enrollment to the end of the intervention or at 6 weeks, which ever is earlier.

    All hospitalizations of the caregivers' patient from enrollment to end of intervention

Sponsors and collaborators

Lead sponsor

Weill Medical College of Cornell University

Other

Collaborators

  • National Institute on Aging (NIA)
  • Visiting Nurse Service of New York

Registry information

Official study title

Developing and Piloting a Multi-component Technology-based Care Intervention to Address Patient Symptoms and Caregiver Burden in Home Hospice

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Jan 28, 2020
Registry last updated
Aug 7, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.